BRICS anti-drugs summit in India confronts global synthetic drug trade rooted in neoliberal supply chains and cross‑border inequities
Original framing: “India to host two-day BRICS anti-drugs meet” — The Hindu
Scenario modelling predicts that without coordinated regulation of precursor chemicals and investment in public health, synthetic drug markets could double by 2035, spilling over into neighboring BRICS nations. Climate‑induced migration may further amplify demand in vulnerable regions. The summit’s current agenda lacks forward‑looking risk assessments and adaptive policy design.
The BRICS anti‑drugs summit, while framed as a security triumph, must confront the historic entanglement of drug trade with colonial exploitation and modern neoliberal supply chains.
Integrating indigenous stewardship, cross‑cultural harm‑reduction models, and rigorous scientific monitoring can transform enforcement into a holistic public‑health strategy. By amplifying marginalized voices and employing future scenario modelling, the consortium can pre‑empt market expansions driven by climate‑migration and economic precarity. A trickster lens reveals that the same structures that police drugs also profit from them, demanding transparent, accountable governance. Ultimately, coordinated precursors regulation, community‑led interventions, and culturally resonant knowledge exchange will reshape the synthetic drug landscape across BRICS nations.